PrimeRFP SCOUT · Federal Contract Recompete Brief · MHS GENESIS

W81K0026FA070Pharmacist services — Acmesolv, LLC

Acmesolv, LLC holds $12.8M across 13 federal awards, concentrated at Department of Defense (DOD). Competition previously drew 19 offers. Set-aside status: SBA. Recompete timing centers on the Sep 30, 2030 PoP end — agencies typically plan 12–18 months ahead.

W40m Mrc0 West

Awarding office

Acmesolv, LLC

Recipient

Sep 30, 2030

PoP end

$0

Obligated

$38.1M

Potential

621111

NAICS

Q517

PSC

MHS GENESIS

Vehicle

SBA

Set-aside

19 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Acmesolv, LLC — $90

Contract facts

SBA

Contract numberW81K0026FA070

Also listed asHT001525D9013-W81K0026FA070

AgencyW40m Mrc0 West

Awarding officeW40m Mrc0 West

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAcmesolv, LLC

CAGE8NKV0

UEISBDDBRVCUXM9

NAICS621111

PSCQ517

VehicleMHS GENESIS

Parent IDIQ / IDVHT001525D9013

Place of performanceSAN ANTONIO TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startApr 1, 2026

PoP end (current)Sep 30, 2030

Obligated$0

Current value$38.1M

Potential value$38.1M

PHARMACIST SERVICES AT BAMC, JBSA FORT SAM HOUSTON, TX is a federal SBA award for W40m Mrc0 West held by Acmesolv, LLC. Estimated value $38.1M ($0 obligated). Current period of performance ends Sep 30, 2030. Last award drew 19 bidders. Place of performance: SAN ANTONIO TX.

PHARMACIST SERVICES AT BAMC, JBSA FORT SAM HOUSTON, TX

Recompete timing

Public

● Expiring in 1501 days

Current PoP ends Sep 30, 2030 (1501 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 30, 2029.

Incumbent footprint

Public record

Acmesolv, LLC — $12.8M obligated across 13 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($12.8M) · all agencies

Department of Defense (DOD)$12.8M · 100%General Services Administration (GSA)$8K · 0%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81K0026FA070?

W81K0026FA070 (Pharmacist services) is a W40m Mrc0 West award with a potential value of $38.1M, currently held by Acmesolv, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded W81K0026FA070?

W40m Mrc0 West awarded W81K0026FA070 to Acmesolv, LLC (potential $38.1M).

Who is the incumbent on W81K0026FA070?

Acmesolv, LLC is the incumbent with $12.8M across 13 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2030.

When does Acmesolv, LLC’s W81K0026FA070 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2030. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Mar 30, 2026